Terms: = Lymphoma AND MLLT11, Q13015, 10962, ENSG00000213190, AF1Q AND Prognosis
1 results:
1. A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit-positive Acute Myeloid Leukemia.
Advani AS; Tse W; Li H; Jia X; Elson P; Cooper B; Ali-Osman F; Park J; Rao AV; Rizzieri DA; Wang ES; Cotta CV; Kalaycio M; Sobecks RM; Rouphail B; Maciejewski JP; Fensterl J; Carew JS; Foster B; Rush ML; Tripp B; Adams D; Corrigan D; Griffiths EA; Sekeres MA
Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):113-118. PubMed ID: 33422470
[TBL] [Abstract] [Full Text] [Related]
